Home/Filings/3/0001181431-12-045026
3//SEC Filing

5AM VENTURES LLC 3

Accession 0001181431-12-045026

CIK 0001293310other

Filed

Aug 9, 8:00 PM ET

Accepted

Aug 10, 6:21 PM ET

Size

12.4 KB

Accession

0001181431-12-045026

Insider Transaction Report

Form 3
Period: 2012-08-11
Holdings
  • Common Stock

    572,295
  • Series B-2 Preferred Stock

    Common Stock (624,999 underlying)
  • Series B-1 Preferred Stock

    Common Stock (445,847 underlying)
  • Series C Preferred Stock

    Common Stock (284,513 underlying)
  • Series D Preferred Stock

    Common Stock (344,084 underlying)
Holdings
  • Series B-1 Preferred Stock

    Common Stock (445,847 underlying)
  • Common Stock

    572,295
  • Series C Preferred Stock

    Common Stock (284,513 underlying)
  • Series D Preferred Stock

    Common Stock (344,084 underlying)
  • Series B-2 Preferred Stock

    Common Stock (624,999 underlying)
Holdings
  • Common Stock

    572,295
  • Series D Preferred Stock

    Common Stock (344,084 underlying)
  • Series B-1 Preferred Stock

    Common Stock (445,847 underlying)
  • Series B-2 Preferred Stock

    Common Stock (624,999 underlying)
  • Series C Preferred Stock

    Common Stock (284,513 underlying)
Footnotes (7)
  • [F1]The shares are held as follows: 500,758 shares by 5AM Ventures LLC ("Ventures") and 71,537 shares by 5AM Co-Investors LLC ("Co-Investors"). 5AM Partners LLC is the general partner of Ventures and Co-Investors. The managing directors of 5AM Partners LLC are Dr. John D. Diekman and Andrew J. Schwab.
  • [F2]Each share of Preferred Stock is convertible at any time, at the election of the holder, into one fully paid and nonassessable share of Common Stock, subject to certain anti-dilution adjustments.
  • [F3]No expiration.
  • [F4]The shares are held as follows: 390,116 shares by Ventures and 55,731 shares by Co-Investors.
  • [F5]The shares are held as follows: 546,874 shares by Ventures and 78,125 shares by Co-Investors.
  • [F6]The shares are held as follows: 249,360 shares by Ventures and 35,153 shares by Co-Investors.
  • [F7]The shares are held as follows: 301,570 shares by Ventures and 42,514 shares by Co-Investors.

Issuer

KALOBIOS PHARMACEUTICALS INC

CIK 0001293310

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001178419

Filing Metadata

Form type
3
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 6:21 PM ET
Size
12.4 KB